The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...

Univercells Technologies agreed to collaborate with Repligen to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines. Repligen’s ...

Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...

Immunization has long been a foundation of public health, and recent advances in vaccine science are taking it further. Next-generation vaccines are designed for greater precision and adaptability, ...